Astrotech ( (ASTC) ) has shared an update.
On March 10, 2025, Astrotech Corporation announced the launch of the enhanced TRACER 1000™ Narcotics Trace Detector from its 1st Detect subsidiary. This advanced mass spectrometer is designed to detect synthetic opiates and novel psychoactive substances, offering a significant improvement in portable trace detection. The TRACER 1000 NTD aims to aid law enforcement, border security, and public health agencies in addressing the global synthetic drug crisis by providing rapid and precise identification of illicit substances. The device’s enhanced capabilities could help authorities prevent dangerous drugs from reaching communities, thus positioning Astrotech as a key player in the fight against synthetic drug trafficking.
More about Astrotech
Astrotech Corporation, headquartered in Austin, Texas, is a mass spectrometry company that manages and commercializes scalable companies through its wholly owned subsidiaries. Its subsidiary, 1st Detect, develops and sells trace detectors for the security and detection market, focusing on explosive and narcotics detection with rugged and portable devices.
YTD Price Performance: -4.82%
Average Trading Volume: 12,263
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.1M
Find detailed analytics on ASTC stock on TipRanks’ Stock Analysis page.